← Open Payments lookup

DAVID PENA: Open Payments

NPI 1972807345 · CLOVIS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,894 in 132 payments from 23 companies in 2025. Trend: 2023 $4,681 · 2024 $5,219 · 2025 $4,894

Food & beverage: $4,894
CompanyPaymentsAmount
Corcept Therapeutics15$786
Novo Nordisk Inc23$573
Lilly USA, LLC12$474
ABBVIE INC.12$472
Xeris Pharmaceuticals, Inc.17$398
Amgen Inc.11$379
Ardelyx, Inc.6$280
AstraZeneca Pharmaceuticals LP7$251
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$247
RECORDATI_RARE_DISEASES_INC.6$206

Products named: Korlym, RECORLEV, Ozempic, VRAYLAR, IBSRELA, CAPLYTA, JARDIANCE, MOUNJARO.

Industry payments across CA — which companies pay providers there.